I appreciate your response. why would the merger be kissing your money goodbye? ANI has revenue and they are a hormone manufacturer. Is it that you think we are undervalued heading into the merger? I am certain that Libigel will eventually make money but it will be expensive making that happen. Please explain why you are so sure. Thanks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.